334 related articles for article (PubMed ID: 31418951)
1. Ceria Nanoparticles Meet Hepatic Ischemia-Reperfusion Injury: The Perfect Imperfection.
Ni D; Wei H; Chen W; Bao Q; Rosenkrans ZT; Barnhart TE; Ferreira CA; Wang Y; Yao H; Sun T; Jiang D; Li S; Cao T; Liu Z; Engle JW; Hu P; Lan X; Cai W
Adv Mater; 2019 Oct; 31(40):e1902956. PubMed ID: 31418951
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant and C5a-blocking strategy for hepatic ischemia-reperfusion injury repair.
Zhang X; Hu J; Becker KV; Engle JW; Ni D; Cai W; Wu D; Qu S
J Nanobiotechnology; 2021 Apr; 19(1):107. PubMed ID: 33858424
[TBL] [Abstract][Full Text] [Related]
3. ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury.
Yu H; Jin F; Liu D; Shu G; Wang X; Qi J; Sun M; Yang P; Jiang S; Ying X; Du Y
Theranostics; 2020; 10(5):2342-2357. PubMed ID: 32104507
[TBL] [Abstract][Full Text] [Related]
4. Europium-Doped Cerium Oxide Nanoparticles Limit Reactive Oxygen Species Formation and Ameliorate Intestinal Ischemia-Reperfusion Injury.
Gubernatorova EO; Liu X; Othman A; Muraoka WT; Koroleva EP; Andreescu S; Tumanov AV
Adv Healthc Mater; 2017 Jul; 6(14):. PubMed ID: 28481012
[TBL] [Abstract][Full Text] [Related]
5. Bilirubin nanoparticle preconditioning protects against hepatic ischemia-reperfusion injury.
Kim JY; Lee DY; Kang S; Miao W; Kim H; Lee Y; Jon S
Biomaterials; 2017 Jul; 133():1-10. PubMed ID: 28414974
[TBL] [Abstract][Full Text] [Related]
6. Activation of the PPARγ/NF-κB pathway by A-MPDA@Fe
Mo D; Cui W; Chen L; Meng J; Sun Y; Cai K; Zhang J; Zhang J; Wang K; Luo X
J Mater Chem B; 2024 Jun; 12(23):5722-5733. PubMed ID: 38764419
[TBL] [Abstract][Full Text] [Related]
7. Ceria-Zirconia Nanoparticles as an Enhanced Multi-Antioxidant for Sepsis Treatment.
Soh M; Kang DW; Jeong HG; Kim D; Kim DY; Yang W; Song C; Baik S; Choi IY; Ki SK; Kwon HJ; Kim T; Kim CK; Lee SH; Hyeon T
Angew Chem Int Ed Engl; 2017 Sep; 56(38):11399-11403. PubMed ID: 28643857
[TBL] [Abstract][Full Text] [Related]
8. Kupffer cell-targeting strategy for the protection of hepatic ischemia/reperfusion injury.
Dai Q; Jiang W; Liu H; Qing X; Wang G; Huang F; Yang Z; Wang C; Gu E; Zhao H; Zhang J; Liu X
Nanotechnology; 2021 Apr; 32(26):. PubMed ID: 33472187
[TBL] [Abstract][Full Text] [Related]
9. Prevention of Hepatic Ischemia-Reperfusion Injury by Carbohydrate-Derived Nanoantioxidants.
Long Y; Wei H; Li J; Li M; Wang Y; Zhang Z; Cao T; Carlos C; German LG; Jiang D; Sun T; Engle JW; Lan X; Jiang Y; Cai W; Wang X
Nano Lett; 2020 Sep; 20(9):6510-6519. PubMed ID: 32786929
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic Treatment with Cerium Oxide Nanoparticles Attenuate Hepatic Ischemia Reperfusion Injury in Sprague Dawley Rats.
Manne NDPK; Arvapalli R; Graffeo VA; Bandarupalli VVK; Shokuhfar T; Patel S; Rice KM; Ginjupalli GK; Blough ER
Cell Physiol Biochem; 2017; 42(5):1837-1846. PubMed ID: 28750366
[TBL] [Abstract][Full Text] [Related]
11. An antioxidant nanodrug protects against hepatic ischemia-reperfusion injury by attenuating oxidative stress and inflammation.
Zhang S; Cao Y; Xu B; Zhang H; Zhang S; Sun J; Tang Y; Wang Y
J Mater Chem B; 2022 Sep; 10(37):7563-7569. PubMed ID: 35389415
[TBL] [Abstract][Full Text] [Related]
12. Nanotheranostics for the Management of Hepatic Ischemia-Reperfusion Injury.
Guan Y; Yao W; Yi K; Zheng C; Lv S; Tao Y; Hei Z; Li M
Small; 2021 Jun; 17(23):e2007727. PubMed ID: 33852769
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of grape seed proanthocyanidins against liver ischemic reperfusion injury: particularly in diet-induced obese mice.
Song X; Xu H; Feng Y; Li X; Lin M; Cao L
Int J Biol Sci; 2012; 8(10):1345-62. PubMed ID: 23139633
[TBL] [Abstract][Full Text] [Related]
14. Protective Effect of Epigallocatechin Gallate in Ischemia-Reperfusion Injury of Rat Skeletal Muscle.
Ergün Y; Kılınç M; Aral M; Hedef A; Kaya E
J Surg Res; 2020 Mar; 247():1-7. PubMed ID: 31816476
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and preventive effects of platinum nanoparticles as reactive oxygen species scavengers on hepatic ischemia/reperfusion injury in mice.
Katsumi H; Fukui K; Sato K; Maruyama S; Yamashita S; Mizumoto E; Kusamori K; Oyama M; Sano M; Sakane T; Yamamoto A
Metallomics; 2014 May; 6(5):1050-6. PubMed ID: 24658875
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous Hollow Manganese Doped Ceria Nanoparticle for Effectively Prevention of Hepatic Ischemia Reperfusion Injury.
Si P; Lei J; Yang C; Zhang P; Li X; Zheng S; Li Q; Zhang J
Int J Nanomedicine; 2023; 18():2225-2238. PubMed ID: 37131546
[TBL] [Abstract][Full Text] [Related]
17. Ceria Nanozymes with Preferential Renal Uptake for Acute Kidney Injury Alleviation.
Zhang DY; Liu H; Li C; Younis MR; Lei S; Yang C; Lin J; Li Z; Huang P
ACS Appl Mater Interfaces; 2020 Dec; 12(51):56830-56838. PubMed ID: 33319561
[TBL] [Abstract][Full Text] [Related]
18. Bio-distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice.
Hirst SM; Karakoti A; Singh S; Self W; Tyler R; Seal S; Reilly CM
Environ Toxicol; 2013 Feb; 28(2):107-18. PubMed ID: 21618676
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Cerium Oxide (CeO
Özer A; Şengel N; Küçük A; Yığman Z; Özdemir Ç; Kılıç Y; Dursun AD; Bostancı H; Kip G; Arslan M
Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792935
[No Abstract] [Full Text] [Related]
20. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]